725 related articles for article (PubMed ID: 28239999)
1. Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment.
Hanif F; Muzaffar K; Perveen K; Malhi SM; Simjee ShU
Asian Pac J Cancer Prev; 2017 Jan; 18(1):3-9. PubMed ID: 28239999
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Han J; Puri RK
J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
[TBL] [Abstract][Full Text] [Related]
3. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
[TBL] [Abstract][Full Text] [Related]
4. Treatment of elderly patients with glioblastoma: a systematic evidence-based analysis.
Zarnett OJ; Sahgal A; Gosio J; Perry J; Berger MS; Chang S; Das S
JAMA Neurol; 2015 May; 72(5):589-96. PubMed ID: 25822375
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.
Konar SK; Bir SC; Maiti TK; Nanda A
J Neurosurg Pediatr; 2017 Feb; 19(2):239-248. PubMed ID: 27813458
[TBL] [Abstract][Full Text] [Related]
6. Cerebellar glioblastoma multiforme in an adult.
Hur H; Jung S; Jung TY; Kim IY
J Korean Neurosurg Soc; 2008 Apr; 43(4):194-7. PubMed ID: 19096643
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
[TBL] [Abstract][Full Text] [Related]
9. [Glioblastoma multiforme--new hope due to modern therapeutical approaches].
Gautschi OP; Cadosch D; Collen TD; Land M; Hoederath P; Hildebrandt G; Fournier JY; Hundsberger T
Praxis (Bern 1994); 2010 Mar; 99(5):295-308. PubMed ID: 20205087
[TBL] [Abstract][Full Text] [Related]
10. Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience.
Ciammella P; Galeandro M; D'Abbiero N; Podgornii A; Pisanello A; Botti A; Cagni E; Iori M; Iotti C
Clin Neurol Neurosurg; 2013 Sep; 115(9):1609-14. PubMed ID: 23453151
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of Glioblastoma Multiforme-Literature Review.
Grochans S; Cybulska AM; Simińska D; Korbecki J; Kojder K; Chlubek D; Baranowska-Bosiacka I
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626018
[TBL] [Abstract][Full Text] [Related]
12. Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
Duma CM; Kim BS; Chen PV; Plunkett ME; Mackintosh R; Mathews MS; Casserly RM; Mendez GA; Furman DJ; Smith G; Oh N; Caraway CA; Sanathara AR; Dillman RO; Riley AS; Weiland D; Stemler L; Cannell R; Abrams DA; Smith A; Owen CM; Eisenberg B; Brant-Zawadzki M
J Neurosurg; 2016 Dec; 125(Suppl 1):40-49. PubMed ID: 27903197
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs as Multifaceted Players in Glioblastoma Multiforme.
Mercatelli N; Galardi S; Ciafrè SA
Int Rev Cell Mol Biol; 2017; 333():269-323. PubMed ID: 28729027
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review.
Batash R; Asna N; Schaffer P; Francis N; Schaffer M
Curr Med Chem; 2017; 24(27):3002-3009. PubMed ID: 28521700
[TBL] [Abstract][Full Text] [Related]
15. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
[TBL] [Abstract][Full Text] [Related]
16. Canadian recommendations for the treatment of glioblastoma multiforme.
Mason WP; Maestro RD; Eisenstat D; Forsyth P; Fulton D; Laperrière N; Macdonald D; Perry J; Thiessen B;
Curr Oncol; 2007 Jun; 14(3):110-7. PubMed ID: 17593983
[TBL] [Abstract][Full Text] [Related]
17. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma multiforme: State of the art and future therapeutics.
Wilson TA; Karajannis MA; Harter DH
Surg Neurol Int; 2014; 5():64. PubMed ID: 24991467
[TBL] [Abstract][Full Text] [Related]
19. Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiforme.
Gainer JL; Sheehan JP; Larner JM; Jones DR
J Neurosurg; 2017 Feb; 126(2):460-466. PubMed ID: 27177177
[TBL] [Abstract][Full Text] [Related]
20. Cerebellar giant cell glioblastoma multiforme in an adult.
Mishra SS; Behera SK; Dhir MK; Senapati SB
J Neurosci Rural Pract; 2014 Jul; 5(3):295-7. PubMed ID: 25002780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]